FCGR2B and plasma cell myeloma: In addition, the Fc gamma receptor 2B (FcɣRIIB) is expressed on plasma cells, and may provide another portal of ADC entry into myeloma cells [17], thereby potentially enhancing cytotoxicity and highlighting why ADCs could be especially effective against myeloma.